Results 191 to 200 of about 213,592 (225)
Some of the next articles are maybe not open access.

Biomarkers in Barrett's esophagus

Gastrointestinal Endoscopy Clinics of North America, 2003
This article provides a framework for clinicians who are attempting the difficult task of interpreting the Barrett's biomarker literature with the goal of improving care for their patients. Although many articles. including more that 60 proposed biomarkers, have been published on this subject, only a few describe phase 3 and 4 studies that are of ...
Brian J, Reid   +2 more
openaire   +2 more sources

BARRETT'S ESOPHAGUS AND ADENOCARCINOMA

Annual Review of Medicine, 1987
Barrett's esophagus represents an epithelial metaplasia in which a columnar lining replaces normal squamous epithelium of the esophagus. It occurs in at least 10% of patients with chronic gastroesophageal reflux and is associated with an increased risk of adenocarcinoma of the esophagus.
B J, Reid, W M, Weinstein
openaire   +2 more sources

Gastritis in Barrett's esophagus

World Journal of Surgery, 1995
AbstractDuodenogastric reflux has been implicated in the pathogenesis of complicated Barrett's esophagus and gastric ulceration. A group of 123 Barrett's patients were followed for a mean of 41 months; 9 (7%) developed gastric ulceration (GU). Of the Barrett's patients treated by antireflux surgery, 14% developed GU.
R J, Mason, C G, Bremner
openaire   +2 more sources

Barrett's esophagus

Postgraduate Medicine, 1989
PreviewBarrett's esophagus is a premalignant condition that should be suspected in any patient presenting with signs and symptoms of chronic reflux esophagitis. The condition itself is asymptomatic, so a high index of suspicion in patients with reflux symptoms is the key to diagnosis.
S E, Wilson, D, Arnstein
openaire   +2 more sources

Screening for Barrett’s Esophagus

Gastroenterology Clinics of North America, 2015
There is substantial interest in identifying patients with premalignant conditions such as Barrett's esophagus (BE), to improve outcomes of subjects with esophageal adenocarcinoma. However, there is limited consensus on the rationale for screening, the appropriate target population, and optimal screening modality. Recent progress in the development and
Milli, Gupta, Prasad G, Iyer
openaire   +2 more sources

Endotherapy for Barrett's Esophagus

American Journal of Gastroenterology, 2012
Endotherapy is now the mainstay of therapy for Barrett's associated neoplasia. The approach should begin with confirmation of neoplasia by a gastrointestinal pathologist, patient counseling, and appropriate endoscopic work up. Detailed examination with high-resolution white light endoscopy is the most important tool for detection of neoplasia.
Vani J A, Konda, Irving, Waxman
openaire   +2 more sources

Barrett's Esophagus

New England Journal of Medicine, 2010
Stuart J, Spechler, Rhonda F, Souza
openaire   +4 more sources

Cryotherapy for Barrett’s Esophagus

Gastrointestinal Endoscopy Clinics of North America, 2017
Cryotherapy or cryoablation involves the freezing of tissues to destroy unwanted tissue or to control bleeding. Endoscopic cryotherapy has been developed for gastrointestinal application by through-the-scope noncontact delivery of compressed carbon dioxide gas or liquid nitrogen (cryospray) or contact balloon cryoablation.
openaire   +2 more sources

Endomicroscopy of Barrett’s Esophagus

Gastroenterology Clinics of North America, 2010
Endomicroscopy is a remarkable technical advance in gastrointestinal mucosa imaging. In 2003, Kiesslich and colleagues described the first human use of contrast-aided confocal laser endomicroscopy (CLE) as a novel technique for in vivo microscopic imaging of the gastrointestinal mucosa.
openaire   +2 more sources

Barrett's Esophagus and Adenocarcinoma

2001
Barrett’s esophagus is an endoscopically recognized change in the esophageal epithelium of any length, which is confirmed at biopsy to contain intestinal metaplasia (Fig. 1; 1). The definition of Barrett’s esophagus has changed over the past 20 yr (2).
John Yalam, Richard E. Sampliner
openaire   +1 more source

Home - About - Disclaimer - Privacy